-
When FDA and Advisory Committees Disagree: Study Investigates Gaps Opens in a new window)
About one in five US Food and Drug Administration (FDA) new drug approvals or safety decisions run counter to outside advisory committee advice.
-
The FDA Disagrees With its Own Expert Panels How Often? Opens in a new window)
A new analysis finds the agency disagreed with its expert advisory panels about one-fifth of the time.
-
Is Great Information Good Enough? Evidence From Physicians As Patients
-
Could a UK-US Trade Deal Make Pharmaceuticals Pricier?
What sort of impact could trade deal compromises have on the price of pharmaceuticals?
-
National and State Estimates of Lost Earnings From Cancer Deaths in the United States
What is the estimated monetary value of lost earnings due to cancer deaths in the United States nationally and by state?
-
Attempt to Replicate Clinical Trials With Real-World Data Generates Real-World Criticism, Too Opens in a new window)
It’s one of the most seductive ideas in medicine - “real-world evidence”. Does it work? It depends on who you ask.
-
50 Maps That Explain How America Lives, Spends, and elieves Opens in a new window)
The US is a large, complex place, and maps can provide a big-picture sense of how we're doing as a community and as citizens.
-
Angered By High Health Care Spending? Here's What Maryland Is Doing Opens in a new window)
In 2014, the state of Maryland took direct aim at this profitless profligacy, enacting a bold (dare I say European?) approach.
-
Five Things We Found In The FDA’s Hidden Device Database Opens in a new window)
The Food and Drug Administration has published the once hidden database online, revealing 5.7 million incidents publicly for the first time.
-
Flawed WHO Study Could Jeopardize Patients' Access to Cancer Medicines Opens in a new window)
In this report the WHO claims that the industry’s current pricing approach “makes cancer medicines unaffordable, preventing the full benefit of the medicines from being realized.”
-
Factors Influencing Pharmaceutical Pricing - A Scoping Review of Academic Literature in Health Science
Bibliometric and content description of health science academic literature and ad hoc analysis of grey literature on factors influencing pharmaceutical pricing on databases commonly accessed by healthcare professionals.
-
What the U.S. Medical System Can Learn From Estonia Opens in a new window)
Americans waste time and money filling out paperwork and repeating tests in the doctor’s office. A small Baltic nation has found a better way.
-
Should We Overhaul the Drug Development and Pricing System?
The high cost of pharmaceuticals gets a lot of public attention, but that is only the endpoint of a long pipeline that moves drugs from the laboratory, to clinical testing, to approval, and into the marketplace.
-
Blurring the Expense of Medical Care Opens in a new window)
Health care is one of the most expensive items people buy each year and yet most Americans haven’t a clue what all of this costs.
-
Medical Cost Trend: Behind the Numbers 2020
